Westgeest, H. M. http://orcid.org/0000-0002-5735-3638
Kuppen, M. C. P.
van den Eertwegh, A. J. M.
de Wit, R.
Bergman, A. M.
van Moorselaar, R. J. A.
Coenen, J. L. L. M.
van den Bergh, A. C. M.
Somford, D. M. http://orcid.org/0000-0002-5277-6586
Mehra, N. http://orcid.org/0000-0002-4794-1831
van Oort, I. M. http://orcid.org/0000-0002-8002-1869
Aben, K. K. H.
Gerritsen, W. R. http://orcid.org/0000-0001-8754-1210
Uyl-de Groot, C. A.
Article History
Received: 29 October 2020
Revised: 6 February 2021
Accepted: 22 February 2021
First Online: 21 March 2021
Compliance with ethical standards
:
: HMW reports travel expenses paid by Ipsen and honoraria from Roche and Astellas. MCPK reports travel expenses from Ipsen. AJMvdE reports study grants from Sanofi and Roche, travel expenses from MSD Oncology, Roche, Pfizer, and Sanofi, honoraria from Bristol-Myers Squibb, and consulting/advisory role for Bristol-Myers Squibb, MSD Oncology, Amgen, Roche, Novartis, Sanofi, Pfizer, Ipsen, and Merck. RdW reports consulting/advisory role for Sanofi, Merck Sharp&Dohme, Roche/Genentech, Janssen, Bayer, Clivis; honoraria from Sanofi, Merck Sharp&Dohme; and research funding from Sanofi and Bayer. AMB reports research funding from Sanofi, Astellas, and Bayer; consulting/advisory role for Sanofi, Astellas, and Bayer; travel expenses for Sanofi, Astellas, and Bayer and speakers bureau for Sanofi, Astellas, Bayer, and Janssen. RJAvM reports honoraria from Astellas, AstraZeneca, Bayer, Janssen and Sanofi-Genzyme. JLLMC reports consulting/advisory role for Sanofi. DMS reports research funding from Astellas and consulting/advisory role for Astellas and Janssen. NM reports research funding (institute) for Astellas, Janssen, Pfizer, Roche, and Sanofi Genzyme; advisory role (compensated and institutional) for Roche, MSD, BMS, Bayer, Astellas, and Janssen; and travel expenses from Astellas and MSD. IMvO reports consulting/advisory role for Astellas, Janssen, Bayer, Roche, Mdx health; and research funding from Astellas, Janssen, Bayer. WRG reports speakers fees from Bayer and MSD; consulting/advisory role for Bristol-Myers Squibb, Astellas, Bayer, Sanofi, Amgen; and research funding from Bayer, Astellas, Janssen-Cilag. CAUdG reports research funding from Boehringer Ingelheim, Astellas, Celgene, Sanofi, Janssen-Cilag, Bayer, Amgen, Genzyme, Merck, Glycostem Therapeutics, Astra Zeneca, Roche, and Merck. All remaining authors have declared no conflicts of interest.